↑ Rising
Health
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
GLP‑1 weight‑loss drugs tied to a rare vitamin‑deficiency brain disorder, shaking confidence in their safety.
Zepbound
7 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Zepbound
This hub groups 7 separate news trends connected to Zepbound, spanning July 25, 2026 through September 15, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 44 article observations and 43 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight-loss drugs show promise for sleep apnea
GLP-1 weight-loss drugs could cut sleep-apnea rates, opening a new market and clinical pathway for millions.
◼ Archived
Health
New Research Shows a Strong Link Between This GLP Medication and Hair Loss. Experts Weigh In.
New research has linked a popular GLP medication to increased hair loss, sparking discussions among health experts.
◼ Archived
Health
🔮 fades ✓
GLP-1s Left Their Hair 'Falling Out In Fistfuls'
Recent reports indicate that users of GLP-1 receptor agonists are experiencing significant hair loss, sparking medical interest in these medications.
◼ Archived
Health
🔮 fades ✓
Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk
A popular diabetes drug may also protect against heart attacks, but the mechanism is still unclear.
◼ Archived
Business
🔮 fades ✓
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
Eli Lilly's stock surges as demand for its weight-loss drugs continues to drive revenue growth.
◼ Archived
Health
🔮 fades ✓
Should We Be Concerned About Muscle Loss With GLP-1s?
Medical experts are raising alarms over the risk of muscle loss and increased frailty in older adults using GLP-1 weight loss medications.